Considering the IRX4 isoform-specific expression, our study suggests that IRX4 can have distinct roles in PCa, which suggests the clinical importance of isoform-specific therapeutic targets in improving PCa patient care. The gene discussed is IRX4; the disease is posterior cortical atrophy.